Ali Haider
Founder, President and CEO, Lilia AI
Ali Haider is a medical technology entrepreneur, scientist and inventor leading transformative scientific innovation as founder, president, and CEO of Lilia AI, Inc., a healthcare technology company developing the next generation of AI-powered medical devices. Lilia AI’s first technology is an AI diagnostic algorithm for brain aneurysms, with additional products including AI algorithms for stroke diagnosis and the clinical radiology workflow.
Haider's unique value as a healthcare AI founder is shaped by more than a decade of firsthand experience in neurosurgery, oncology and clinical research at some of the most respected medical institutions in the world. He was a researcher at The University of Texas M.D. Anderson Cancer Center, the nation’s #1 cancer center, working directly with leaders responsible for major innovations in neuro-oncology. Haider became one of the most productive junior researchers at MD Anderson, building capabilities in data analysis, complex study design and cross-functional clinical collaboration: skills that now directly inform Lilia AI’s product development and validation strategy. Haider was also a researcher at the University of Toronto’s Hospital for Sick Children, where he gained additional experience in pediatric brain tumor biology, translational modeling and the complexities of high-acuity care environments.
He is an award-winning medical scientist with two national research fellowships and more than 150 peer-reviewed scientific publications, national conference presentations and textbook chapters combined. Haider has been published in world-renowned medical research journals such as Nature Communications, Neuro-Oncology, Journal of Neuroimmunology, Journal of Neurosurgery, and Journal of Neuro-Oncology, placing his scientific output among the top clinical researchers in the world.
Haider's academic background spans medicine, engineering and business, a dynamic combination that aligns directly with the needs of modern healthcare technology companies. He is currently pursuing an M.S. in Computer Science from the University of Pennsylvania, with a focus on AI and Digital Medicine, and an MBA in Entrepreneurship at Rice Business, where he was awarded an academic merit scholarship as one of the top candidates in his cohort. Haider completed three years of medical school at Texas A&M College of Medicine, earned an Honors B.S. in Molecular Biology in three years from the University of Texas at Arlington (magna cum laude), and entered medical school at age 20.